Usa Financial Portformulas Corp Bristol Myers Squibb CO Transaction History

Usa Financial Portformulas Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Nov 27, 2023	SELL	$65.71 - $74.53 $14,390 - $16,322	-219 Reduced 91.25%	21 $1,000
Q3 2022 Oct 24, 2022	BUY	$0.13 - $76.84 $26 - $15,368	200 Added 500.0%	240 $17,000
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $363 - $399	-5 Reduced 11.11%	40 $3,000
Q4 2021 Feb 10, 2022	SELL	$53.63 - $62.52 $42,206 - $49,203	-787 Reduced 94.59%	45 $3,000
Q3 2021 Nov 08, 2021	BUY	$59.17 - $69.31 $46,566 - $54,546	787 Added 1748.89%	832 $49,000
Q2 2021 Jul 29, 2021	BUY	$61.91 - $67.42 $247 - $269	4 Added 9.76%	45 $3,000
Q1 2021 May 06, 2021	SELL	$59.34 - $66.74 $75,777 - $85,226	-1,277 Reduced 96.89%	41 $3,000
Q4 2020 Jan 29, 2021	BUY	$57.74 - $65.43 $72,983 - $82,703	1,264 Added 2340.74%	1,318 $82,000
Q3 2020 Oct 09, 2020	BUY	$57.43 - $63.64 $2,354 - $2,609	41 Added 315.38%	54 $3,000
Q1 2020 Apr 13, 2020	BUY	$46.4 - $67.43 $603 - $876	13 New	13 $1,000
Q1 2019 May 14, 2019	SELL	$45.12 - $53.8 $400,846 - $477,959	-8,884 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $433,183 - $561,735	8,884 New	8,884 $552,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Usa Financial Portformulas Corp, based on Form 13F filings with the SEC.

Stay updated on Usa Financial Portformulas Corp with notifications on news.